Zhenhua Fan

ORCID: 0000-0001-5994-3036
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Organ Transplantation Techniques and Outcomes
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Target Tracking and Data Fusion in Sensor Networks
  • Infrared Target Detection Methodologies
  • Advanced Measurement and Detection Methods
  • Topic Modeling
  • Recycling and utilization of industrial and municipal waste in materials production
  • Central Venous Catheters and Hemodialysis
  • Glass properties and applications
  • Natural Language Processing Techniques
  • BRCA gene mutations in cancer
  • DNA Repair Mechanisms
  • Multimodal Machine Learning Applications
  • Hepatitis Viruses Studies and Epidemiology
  • MRI in cancer diagnosis
  • Higher Education and Teaching Methods
  • Advanced Algorithms and Applications
  • Milk Quality and Mastitis in Dairy Cows
  • Military Defense Systems Analysis
  • Pigment Synthesis and Properties
  • Advanced Computational Techniques and Applications
  • Liver Diseases and Immunity
  • Vehicle Noise and Vibration Control

Capital Medical University
2015-2024

Beijing Shijitan Hospital
2015-2024

Chongqing University
2024

Capital University
2021-2023

Jiangsu University of Science and Technology
2023

Alibaba Group (United States)
2022

Peking University Shougang Hospital
2019-2021

China Electronics Technology Group Corporation
2017-2021

Peking University
2016-2020

Peking University Cancer Hospital
2018-2019

We introduce PreCo, a large-scale English dataset for coreference resolution. The is designed to embody the core challenges in coreference, such as entity representation, by alleviating challenge of low overlap between training and test sets enabling separated analysis mention detection clustering. To strengthen training-test overlap, we collect large corpus 38K documents 12.5M words which are mostly from vocabulary English-speaking preschoolers. Experiments show that with higher error on...

10.18653/v1/d18-1016 article EN cc-by Proceedings of the 2021 Conference on Empirical Methods in Natural Language Processing 2018-01-01

Abstract We conducted a single-center randomized trial to compare the efficacy of 8 mm Fluency covered stent and bare in transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic portal hypertension. From January 2006 December 2010, (experimental group) or (control was used 131 127 patients, respectively. The recurrence rates gastrointestinal bleeding (18.3% vs. 33.9%, P = 0.004) refractory hydrothorax/ascites (6.9% 16.5%, 0.019) experimental group were significantly lower than...

10.1038/srep21011 article EN cc-by Scientific Reports 2016-02-15

Abstract Either acute or sub-acute Budd–Chiari syndrome (BCS) with diffuse occlusion of hepatic veins has a high mortality rate and remains challenging for clinical treatment. We aimed to evaluate the feasibility safety transjugular intrahepatic portosystemic shunt (TIPS) as treatment BCS veins. From January 2007 December 2010, 100 patients were randomly recruited onto this study 91 treated TIPS. 14 defined group 86 group. Patients had significantly higher jaundice whereas lower abdominal...

10.1038/srep36380 article EN cc-by Scientific Reports 2016-11-02

10.1016/j.image.2015.07.001 article EN Signal Processing Image Communication 2015-07-10

Portal vein hypertension (PVH) in liver cirrhosis complicated with portal venous thrombosis (PVT) has been mainly treated transjugular intrahepatic portosystemic shunt (TIPS). The clinical effects of TIPS have confirmed, however, no large-scale studies focused on technical analyses and a long-term follow-up, especially thrombotic total occlusion main (MPV). To demonstrate critical techniques outcome cirrhosis-related MPV, 98 patients diagnosed related MPV from January 2000 to 2010 were...

10.1038/s41598-017-11455-y article EN cc-by Scientific Reports 2017-09-01

To evaluate the efficacy of main portal vein stents combined with iodine-125 (125I) to treat tumor thrombus.From January 1, 2010 2015, 111 patients were diagnosed liver cancer thrombus. They non-randomly assigned undergo treatment transarterial chemoembolization (TACE)/transarterial embolization (TAE) + 125I implantation (Group A) and TACE/TAE only B). After operation, scheduled follow-up was performed at 6, 12 24 mo. The recorded information included clinical manifestations, survival rate,...

10.4251/wjgo.v10.i12.496 article EN cc-by-nc World Journal of Gastrointestinal Oncology 2018-12-14

Background Hepatic encephalopathy (HE) remains an enormous challenge in patients who undergo transjugular intrahepatic portosystemic shunt (TIPS) implantation. The preoperative indocyanine green retention rate at 15 min (ICG-R15), as one of the liver function assessment tools, has been developed a prognostic indicator undergoing surgery, but there are limited data on its role TIPS. Aim To determine whether ICG-R15 can be used for prediction post-TIPS HE decompensated cirrhosis with portal...

10.3748/wjg.v27.i5.416 article EN cc-by-nc World Journal of Gastroenterology 2021-01-29

To assess the correlation and agreement between hepatic venous pressure gradient (HVPG) portal (PPG) in patients with autoimmune liver diseases (ALD) hypertension, to investigate extent which vein collateralization affects accuracy of this assessment.Ninety-eight ALD 2017 2021 who underwent transjugular intrahepatic portosystemic shunt conventional innovative 15 mL pressurized contrast were selected measure wedged (WHVP) calculate HVPG PPG. Pearson's was used for analysis two groups....

10.1111/hepr.13939 article EN Hepatology Research 2023-06-25

Portal hypertension (PHT) in patients with alcoholic cirrhosis causes a range of clinical symptoms, including gastroesophageal varices and ascites. The hepatic venous pressure gradient (HVPG), which is easier to measure, has replaced the portal (PPG) as gold standard for diagnosing PHT practice. Therefore, attention should be paid correlation between HVPG PPG.To explore PPG PHT.Between January 2017 June 2020, 134 who met inclusion criteria underwent various measurements during transjugular...

10.4240/wjgs.v15.i11.2490 article EN World Journal of Gastrointestinal Surgery 2023-11-26

Abstract The patients of liver cirrhosis associated with portal vein thrombosis (PVT) can be effectively treated by transjugular intrahepatic portosystemic stent shunt (TIPS). Although the corresponding TIPS procedures have already performed on to different types PVT, are not specific and relationship between PVT technical success rate is unclear. What’s more, we aimed explore survival vascular patency immediately after TIPS. 191 subjects underwent retrospective assessment. Appropriate were...

10.1038/srep33069 article EN cc-by Scientific Reports 2016-09-13

Transjugular intrahepatic portosystemic shunt (TIPS) reduces the portal venous pressure of patients with hepatopulmonary syndrome (HPS).To describe who underwent TIPS for treatment HPS.A retrospective study was performed on 81 HPS and gastrointestinal hemorrhage treated TIPS. Thirty through main vein (group A), 24 left branch B), 27 right C). The partial arterial oxygen (PaO2), alveolar-to-arterial gradient (A-aPO2), saturation (SO2), complications were recorded compared. survival rate each...

10.1097/md.0000000000009080 article EN cc-by-nc Medicine 2017-12-01

10.1016/j.inffus.2016.01.004 article EN Information Fusion 2016-02-01

Periductal mastitis (PDM) is a complex benign breast disease with prolonged course and high risk of recurrence after treatment. There are many available treatments for PDM, but none widely accepted. This study aims to evaluate the various treatment failure rates (TFR) different invasive measures by looking at persistence In this way, it sets out inform better clinical decisions in PDM.We searched PubMed, Embase, Cochrane Library databases eligible studies about regimens provided PDM patients...

10.1159/000514419 article EN Breast Care 2021-02-18

Hepatic venous pressure gradient (HVPG) is the gold standard for diagnosis of portal hypertension (PH). However, its use can be limited because it an invasive procedure. Therefore, necessary to explore a non-invasive method assess PH.To investigate correlation computed tomography (CT) perfusion liver with HVPG and Child-Pugh score in hepatitis B virus (HBV)-related PH.Twenty-eight patients (4 female, 24 male) gastroesophageal variceal bleeding induced by HBV-related PH were recruited our...

10.3748/wjg.v28.i42.6068 article EN cc-by-nc World Journal of Gastroenterology 2022-11-09

Hepatic venous pressure gradient (HVPG) is the gold standard for diagnosis of portal hypertension (PH), invasiveness and potential risks in process measurement limited its widespread use.To investigate correlation computed tomography (CT) perfusion parameters with HVPG PH, quantitatively assess blood supply changes liver spleen parenchyma before after transjugular intrahepatic portosystemic shunt (TIPS).Twenty-four PH related gastrointestinal bleeding patients were recruited this study, all...

10.4240/wjgs.v15.i4.664 article EN World Journal of Gastrointestinal Surgery 2023-04-22

Abstract To compare changes in spectral CT iodine densities of hepatic parenchyma and vessels before after transjugular intrahepatic portosystemic shunt (TIPS) hepatitis B virus (HBV)-related liver cirrhosis. Twenty-five patients with HBV-related cirrhosis who received TIPS for gastroesophageal varices bleeding were recruited. Each patient underwent three phases contrast within 4 weeks, the raw data reconstructed at 1.25-mm-thick slices. Iodine density (in milligrams per milliliter) was...

10.1038/s41598-021-89764-6 article EN cc-by Scientific Reports 2021-05-18

Abstract BRCA 1/2 genes are the most frequently germline mutated DNA ‐repair genes, and survival of carriers has been extensively explored in breast cancer. However, prevalence mutations non‐ largely unknown a large cohort unselected cancer patients. Germline 16 were determined using multigene panel 7657 ‐negative patients who for family history or age at diagnosis. Among patients, 257 (3.4%) carried least 1 pathogenic mutation genes. The gene was significantly higher familial cancers (5.2%,...

10.1111/cas.14175 article EN cc-by-nc Cancer Science 2019-08-21

BACKGROUNDMain portal vein tumor thrombus (MPVTT), which has a high incidence, is the major complication of terminal liver cancer.The occurrence MPVTT always negative prognostic factor for patients with hepatocellular carcinoma (HCC).Therefore, attention should be paid to treatment and its complications. AIMTo evaluate efficacy transarterial chemoembolization/transarterial embolization (TACE/TAE)+ 125 I seeds implantation transjugular intrahepatic portosystemic shunt (TIPS) in treating...

10.4251/wjgo.v11.i4.310 article EN cc-by-nc World Journal of Gastrointestinal Oncology 2019-04-15

In recent years, totally implantable venous access port (TIVAP) is increasingly applied in the patients' chemotherapy which was usually involved cancer treatment.1 It necessary for some patients with breast to undergo more than 6 months. addition, drugs are toxic veins particularly peripheral veins.2 So implantation of a TIVAP required as its advantage easy central veins.3 reported that there were significant less complications TIVAPs what other accesses and it could be used entire treatment...

10.1111/tbj.13595 article EN The Breast Journal 2019-09-20

The liver is one of the most important organs in human body, with functions such as detoxification, digestion, and blood coagulation. In terms vascular anatomy, divided into left right by main portal vein, there are three hepatic efferent veins (right, middle, left) two branches. Patients impaired function have increased intrahepatic resistance splanchnic vasodilation, which may lead to an increase pressure gradient (PPG) cause hypertension (PHT). order measure venous (HVPG) can be measured...

10.12998/wjcc.v10.i14.4460 article EN World Journal of Clinical Cases 2022-05-06
Coming Soon ...